{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:37Z","timestamp":1790803177326,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.rmr.2021.04.004","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T09:41:19Z","timestamp":1619516479000},"page":"466-476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose\u00a0: m\u00e9canismes, diagnostic et alternatives th\u00e9rapeutiques"],"prefix":"10.1016","volume":"38","author":[{"given":"S.","family":"Bui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dournes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Macey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Murris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Delhaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2021.04.004_bib0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000377631","article-title":"Fatal hypersensitivity pneumonitis from exposure to fusarium vasinfectum in a home environment: a case report","volume":"166","author":"Dickson","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0340","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pneumo.2013.02.008","article-title":"Hypersensitivity pneumonitis related to Penicillium chrysogenum and mesophilic Streptomyces: the usefulness of the Medical Indoor Environment Councelor (MIEC)","volume":"69","author":"Tiotiu","year":"2013","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.rmr.2021.04.004_bib0345","doi-asserted-by":"crossref","first-page":"843763","DOI":"10.1155\/2011\/843763","article-title":"Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis","volume":"2011","author":"Knutsen","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2013.02.003","article-title":"What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?","volume":"12","author":"Liu","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0355","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/IAI.00097-12","article-title":"Neutrophils mediate maturation and efflux of lung dendritic cells in response to Aspergillus fumigatus germ tubes","volume":"80","author":"Park","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.rmr.2021.04.004_bib0360","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/IAI.05530-11","article-title":"Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1\/Th2\/Th17\u00a0microenvironment that requires interleukin-4 (IL-4) and IL-10","volume":"80","author":"Shreiner","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.rmr.2021.04.004_bib0365","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2021.04.004_bib0370","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1398-9995.2005.00887.x","article-title":"Allergic bronchopulmonary aspergillosis","volume":"60","author":"Tillie-Leblond","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmr.2021.04.004_bib0375","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/00365548.2012.695454","article-title":"Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients","volume":"44","author":"Fillaux","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.rmr.2021.04.004_bib0380","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcf.2018.10.001","article-title":"Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: results from the international prospective study \u201cMFIP\u201d","volume":"18","author":"Delhaes","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0385","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JCM.01470-09","article-title":"Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media","volume":"48","author":"Blyth","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0390","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","article-title":"Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review","volume":"47","author":"Pihet","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jcf.2015.01.003","article-title":"Evaluation of mold exposure in cystic fibrosis patients\u2019 dwellings and allergic bronchopulmonary risk","volume":"14","author":"Rocchi","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0400","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mycmed.2015.03.005","article-title":"Indoor fungal exposure: what impact on clinical and biological status regarding Aspergillus during cystic fibrosis","volume":"25","author":"Pricope","year":"2015","journal-title":"J Mycol Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0405","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1016\/j.jcf.2015.06.008","article-title":"Is the home environment an important factor in the occurrence of fungal events in cystic fibrosis?","volume":"14","author":"Sapet","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0410","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.1913752117","article-title":"Timing of fungal spore release dictates survival during atmospheric transport","volume":"117","author":"Lagomarsino Oneto","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2021.04.004_bib0415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.wasman.2018.11.044","article-title":"Estimating Aspergillus fumigatus exposure from outdoor composting activities in England between 2005\u00a0and 14","volume":"84","author":"Williams","year":"2019","journal-title":"Waste Manag"},{"key":"10.1016\/j.rmr.2021.04.004_bib0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fmicb.2015.00089","article-title":"The lung mycobiome: an emerging field of the human respiratory microbiome","volume":"6","author":"Nguyen","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0425","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcf.2018.01.008","article-title":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","volume":"17","author":"Hong","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0430","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IDR.S63621","article-title":"Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy","volume":"9","author":"Burgel","year":"2016","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.rmr.2021.04.004_bib0435","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/thoraxjnl-2012-202412","article-title":"Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum","volume":"68","author":"Baxter","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2021.04.004_bib0440","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antinf.2013.04.001","article-title":"La spectrom\u00e9trie de masse de type MALDI-TOF en mycologie clinique\u00a0: avantages r\u00e9els, \u00e9cueils potentiels [MALDI-TOF mass spectrometry in medical mycology: real advantages and potential pitfalls]","volume":"15","author":"Aliano","year":"2013","journal-title":"J Anti-infect"},{"key":"10.1016\/j.rmr.2021.04.004_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0450","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1128\/JCM.00285-14","article-title":"Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States","volume":"52","author":"Vergidis","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0455","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1378\/chest.12-1363","article-title":"IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis","volume":"143","author":"Baxter","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.04.004_bib0460","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2021.04.004_bib0465","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/JCM.02690-14","article-title":"Evaluation of the Aspergillus Western blot IgG kit for diagnosis of chronic aspergillosis","volume":"53","author":"Oliva","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0470","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mycmed.2012.01.004","article-title":"Aspergillus serology, from yesterday to today for tomorrow","volume":"22","author":"Persat","year":"2012","journal-title":"J Mycol Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0475","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: incidence and prognosis","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.rmr.2021.04.004_bib0480","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.09-2996","article-title":"Sputum Candida albicans presages FEV(1) decline and hospital-treated exacerbations in cystic fibrosis","volume":"138","author":"Chotirmall","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.04.004_bib0485","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-86-4-405","article-title":"Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis","volume":"86","author":"Rosenberg","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0490","doi-asserted-by":"crossref","first-page":"e15346","DOI":"10.1371\/journal.pone.0015346","article-title":"An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus","volume":"5","author":"Agarwal","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2021.04.004_bib0495","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016\u00a0Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2021.04.004_bib0500","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jmii.2013.10.003","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis","volume":"49","author":"Homma","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.rmr.2021.04.004_bib0505","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1378\/chest.14-2347","article-title":"MRI: a new paradigm in imaging evaluation of allergic bronchopulmonary aspergillosis?","volume":"147","author":"Garg","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.04.004_bib0510","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1007\/s00330-016-4218-5","article-title":"Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution","volume":"26","author":"Dournes","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0515","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ppul.23618","article-title":"Aspergillosis and the role of mucins in cystic fibrosis","volume":"52","author":"Cowley","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0520","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1164\/ajrccm.155.1.9001337","article-title":"Bronchial casts in children: a proposed classification based on nine cases and a review of the literature","volume":"155","author":"Seear","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0525","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.chest.2016.07.003","article-title":"Plugs of the air passages: a clinicopathologic review","volume":"150","author":"Panchabhai","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.04.004_bib0530","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2169\/internalmedicine.53.2772","article-title":"Calcium oxalate crystals in the lungs","volume":"53","author":"Hagiya","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0535","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/dc.20517","article-title":"Pulmonary Aspergillus-associated calcium oxalate crystals","volume":"34","author":"Modem","year":"2006","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0540","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/ppul.20499","article-title":"Mucoid impaction: an unusual form of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis","volume":"41","author":"Cakir","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0545","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2011-2883","article-title":"Management of plastic bronchitis with topical tissue-type plasminogen activator","volume":"130","author":"Gibb","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2021.04.004_bib0550","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jpedsurg.2016.03.017","article-title":"Use of serial rigid bronchoscopy in the treatment of plastic bronchitis in children","volume":"51","author":"Soyer","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.rmr.2021.04.004_bib0555","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2169\/internalmedicine.50.4665","article-title":"Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA)","volume":"50","author":"Agarwal","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2021.04.004_bib0565","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1378\/chest.115.2.364","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole","volume":"115","author":"Nepomuceno","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2021.04.004_bib0570","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"Cohen-Cymberknoh","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2021.04.004_bib0575","doi-asserted-by":"crossref","first-page":"e1259","DOI":"10.1542\/peds.2009-2042","article-title":"Bolus methylprednisolone efficacy for uncontrolled exacerbation of cystic fibrosis in children","volume":"125","author":"Ghdifan","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmr.2021.04.004_bib0580","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ppul.20333","article-title":"Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"41","author":"Thomson","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0585","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.rmed.2012.03.001","article-title":"Serologic allergic bronchopulmonary aspergillosis (ABPA-S): long-term outcomes","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.rmr.2021.04.004_bib0590","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002204.pub2","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2021.04.004_bib0595","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002204.pub3","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","author":"Elphick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2021.04.004_bib0600","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/cea.12333","article-title":"Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review","volume":"44","author":"Moreira","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.rmr.2021.04.004_bib0605","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rmr.2021.04.004_bib0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.rmr.2021.04.004_bib0615","first-page":"6","article-title":"Antifungals drug therapeutic monitoring: interrests and limits","volume":"34","author":"Gandia","year":"2020","journal-title":"Lett Pharm Pharmacol Anti-infectieux"},{"key":"10.1016\/j.rmr.2021.04.004_bib0620","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/17425255.2019.1671971","article-title":"Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients","volume":"15","author":"John","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0625","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017\u00a0ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.rmr.2021.04.004_bib0630","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinbiochem.2019.06.003","article-title":"Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS\/MS method in routine clinical practice","volume":"70","author":"Yoon","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.rmr.2021.04.004_bib0635","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/ar.2015.6.0128","article-title":"Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis","volume":"6","author":"Beam","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.rmr.2021.04.004_bib0640","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/JAA.S34579","article-title":"Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab","volume":"5","author":"Collins","year":"2012","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.rmr.2021.04.004_bib0645","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1060028015624204","article-title":"Omalizumab treatment for allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"50","author":"Emiralioglu","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.rmr.2021.04.004_bib0650","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ppul.23612","article-title":"Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients","volume":"52","author":"Nove-Josserand","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0655","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2021.04.004_bib0330","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842521002217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842521002217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:21:04Z","timestamp":1760106064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842521002217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0761842521002217"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2021.04.004","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose\u00a0: m\u00e9canismes, diagnostic et alternatives th\u00e9rapeutiques","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2021.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}